The lipopeptide daptomycin is used as an antibiotic to treat severe infections with gram-
positive pathogens, such as methicillin resistant Staphylococcus aureus (MRSA) and drug …

Daptomycin is a lipopeptide antibiotic used clinically for the treatment of certain types of
Gram-positive infections, including those caused by methicillin-resistant Staphylococcus …

Daptomycin is a highly efficient last-resort antibiotic that targets the bacterial cell membrane.
Despite its clinical importance, the exact mechanism by which daptomycin kills bacteria is …

Daptomycin is a lipopeptide antibiotic that binds to and depolarizes bacterial cell
membranes. Its antibacterial activity requires calcium and correlates with the content of …

Daptomycin is a lipopeptide antibiotic that kills Gram-positive bacteria by membrane
depolarization. While it has long been assumed that the mode of action of daptomycin …

Daptomycin is the first approved member of a new structural class of antibiotics, the cyclic
lipopeptides. The peptide interacts with the lipid matrix of cell membranes, inducing …

Daptomycin is a lipopeptide antibiotic that is used clinically to treat severe infections caused
by Gram-positive bacteria. Its bactericidal action involves the calcium-dependent binding to …

Daptomycin (Cubicin®) is a branched cyclic lipopeptide antibiotic of nonribosomal origin
and the prototype of the acidic lipopeptide family. It was approved in 2003 for the nontopical …

Daptomycin is a cyclic lipopeptide antibiotic, which was discovered in 1987 and entered the
market in 2003. To date, it serves as last resort antibiotic to treat complicated skin infections …

Daptomycin is a lipopeptide antibiotic used clinically to treat infections caused by Gram-
positive bacteria. Laboratory studies have shown that Staphylococcus aureus resistance to …